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ABSTRACTS




Endothelin-1 and big Endothelin-1 in urine and plasma: Investigations tant increased after 24h exposure to 1,25 dose dependently (mean TGF
[pg/10 5 cells] 6 SD; n 5 4):in kidney donors, kidney transplant recipients and patients on dialysis.
M. Zeiler, B.-M. Lo¨ffler*, H.A. Bock, G. Thiel. Kantonsspital Basel,
1,25-D3 mol/LDepartment of nephrology, F. Hoffmann-La Roche*, Basel, Switzer-
land. Big endothelin-1 (bigET-1) is converted to endothelin-1 (ET-1) Solvent 27 28 29 210 212
by endothelin converting enzymes. ET-1 levels are elevated in states
14.366.5 25.169.2* 26.6610.6* 22.767.9* 19.965 15.560.6of kidney transplantation and dialysis. In order to evaluate the alter-
ation of bigET-1 and ET-1 we measured urinary excretion and plasma * Significant difference to solvent; Student’s t-test, p,0.05
levels in kidney donors at one year after nephrectomy (KD),
A synthetic vitamin D analogue (MC1288) showed similar effects atcyclosporin A treated kidney recipients at one year after transplanta-
equimolar concentrations, whereas 25-(OH)D3 at 1027M showed notion (KR) and in haemodialysis patients with residual diuresis (HD).
effect. Results of the ELISA were confirmed in a bioassay system (CCL-Excretion in urine (u-ET-1/min, u-bigET-1/min) was measured in an
64 cells). Since TGF might down regulate MCT proliferation we askedovernight collection. Plasma samples (p-ET-1, p-bigET-1) were drawn
whether growth inhibiting effects of 1,25 are TGF-beta1–3 monoclonalat the end of the urine collection period. In HD all samples were
antibody did not antagonize the growth inhibiting effect of 1,25. Inobtained before a haemodialysis session.
addition TGF in concentrations found in supernatants of MCT treated
with 1,25 did not reduce MCT proliferation. In conclusion: These data
KD KR HD suggest that 1,25 might regulate TGF expression and synthesis in proxi-
Mean6sem n519 n519 n56 mal tubular cells, a growth factor with a key role in renal physiology
(organogenesis) and pathophysiology (glomerulosclerosis, interstitialUrine flow ml/min 1.860.2 1.960.2 0.760.1*§
fibrosis). Growth regulating effects of 1,25 are not TGF transmitted.u-ET-1/min pg/min 10168 110611 3769*§
u-bigET-1/min pg/min 238636 379665* 204670
p-ET-1 pg/ml 1862 2362 2661*
Furosemide (F) inhibits 11b-hydroxysteroid dehydrogenase type 2 (11b-p-bigET-1 pg/ml 1661 2261* 5565*§
OHSD2). B. Vogt, G. Escher, B.M. Frey & F.J. Frey. Abteilung fu¨rCrea-clearance ml/min 7566n 5365* ,5*§
Nephrologie, Universita¨t Bern, Switzerland. 11b-OHSD enzymes regu-
*p , 0.05 vs KD; § p , 0.05 HD vs KR late access of 11b-hydroxy-glucococorticosteroids to the mineralo- and
glucocorticoid receptors. Thus, agents inhibiting 11b-OHSD enhance
As u-ET-1/min is diuresis dependent, HD excreted significantly less glucocorticoid actions and mineralocorticoid effects, such as urinary
ET-1 (despite higher uET-1 concentration) compared to KD and KR. loss of potassium. We have previously shown that F inhibits overall
u-bigET-1/min was comparable to values in KD and KR. p-ET-1 and 11b-OHSD activity in kidney and liver tissue and microsomes and
p-bigET-1 were significantly elevated in HD compared to KD. KR in COS cells transfected with 11b-OHSD1 enzyme (Endocrinology
presented augmented bigET-1 levels in urine and plasma. Changes in 136,1759,1996). The purpose of the present investigation was to estab-
ET-1 do not reflect alterations of bigET-1. bigET-1 values might be lish whether F inhibits specifically the recently cloned 11b-OHSD2
already increased in states where ET-1 values are still in the physiologic enzyme, which supposedly protects the renal mineralocorticoid recep-
range, as seen in KR. Whether the relatively higher levels of bigET-1 tors from promiscuous access of glucocorticoids. F revealed a strong
in KR and HD are due to higher production rate of bigET-1, slower competitive inhibition, when extracts of 11b-OHSD2 transfected COS-1
cells or of renal LLC-PK1 cells were used as an enzyme source of 11b-degradation rate of bigET-1 or higher degradation rate of ET-1, re-
OHSD2. In order to establish whether F inhibits 11b-OHSD1 and 2 inmains to be studied.
the renal target tissue, isolated glomeruli, proximal convoluted tubules,
cortical ascending limbs and cortical collecting tubules (CCT) from
rats were analyzed. High levels of mRNA for mineralocorticoid recep-1,25-Dihydroxycalcitriol (1,25) induces TGF-beta 1 (TGF) synthesis
tors and 11b-OHSD2 by RT-PCR were found in CCT; in CCT thein mouse proximal tubular cells (MCT) in vitro. T. Weinreich, C. Booy,
activity of 11b-OHSD2 was about 5 to 10 times higher than in the otherR.P. Wu¨thrich, M. Landolt, U. Binswanger. Dept. Int. Medicine, Div.
parts of the nephron, an observation in line with the hypothesis of enzymeNephrol., Univ. Hospital, Zu¨rich, Switzerland. Beyond its effects on protection of the mineralocorticoid receptor. 11b-OHSD1 activity was
calcium and bone metabolism 1,25 has been found to provide growth found in all the segments including glomeruli. F inhibited the oxidative
regulatory and immunomodulatory functions in a variety of cells. Hav- activity of 11b-OHSD1 and 11b-OHSD2 in glomeruli and all segments.
ing shown that 1,25 decreases proliferation of proximal tubular cells These data indicate that F enhances the access of 11b-hydroxy-glucocor-
in vitro we asked whether 1,25 might also regulate tubular cell derived ticoids to mineralo- and glucocorticoid receptors, and by that mecha-
growth factor expression. In the present experiment TGF expression nism enhances intracellular gluco- and mineralocorticoid effects.
in MCT exposed to 1,25 was assessed by semiquantitative evaluation
of RT-PCR products and TGF transcripts in MCT were found in-
creased after 12–24h incubation with 1,25, whereas with shorter incuba- Endogenous bradykinin does not mediate the renal hemodynamic ef-
fects of acute hypoxemia. P. To´th-Heyn, C. Mosig, F. Cachat and J.-P.tion (1–6h) no effect was observed. TGF concentration in the superna-
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Guignard. Service de Pe´diatrie, CHUV, Lausanne, Switzerland. Acute attempts to therapeutically neutralise or supply various model systems
with different cytokines failed. The redundancy on the level of cytokinehypoxemia is known to decrease renal perfusion and glomerular filtra-
tion rate (GFR) in newborns. These hypoxemia-induced glomerular receptor and intracellular signalling pathways is much smaller. The
recently discovered janus kinase/signal transducers and activator ofhemodynamic changes are partly mediated by the imbalance of local
vasoactive factors. Bradykinin has been shown to participate in the transcription (Jak/Stat) pathway seems to be instrumental for the signal
transduction of many cytokines. Stat1 is activated by several proin-basic regulation of neonatal glomerular hemodynamics. The plasma
kallikrein-kinin system (KKS) which is activated in asphyxiated new- flammatory cytokines and therefore seems to be important in the
proliferative immune response. The phenotype of Stat1 knock outborns could contribute to the renal effects of hypoxemia in the neonate.
This assumption was assessed in 9 control newborn rabbits and in 9 (KO) mice reveals a unexpected degree of specificity of the defects,
and confirm nonredundant functions of Stat1 in the immune system.newborn rabbits whose bradykinin B2 receptors were blocked by Hoe
140 (300 mg/kg s.c.) prior to the induction of hypoxemia (PaO2 > 40 In this study we wanted to test the hypothesis that Stat1 is an important
mediator of allograft rejections. Islets from Balb/c donors (H-2d) weremmHg). Clearance studies, using inulin and PAH as markers of GFR
and renal blood flow (RBF), respectively, were performed under pento- transplanted under the renal capsule of Stat1 KO mice (H-2b) and wild
type (WT) controls. Recipient mice were rendered diabetic one weekbarbital anesthesia at the age of 5–9 days. In control animals, acute
hypoxemia caused systemic hypotension and an important decrease prior to transplantation and graft function was determined by measur-
ing blood glucose levels. All Stat1 KO mice did reject the islet allograftin RBF (D 5 226 6 5%) and GFR (D 5 213 6 6%). An increase
in the renal vascular resistance (D 5 30 6 12%) and the filtration in a similar time frame as the WT controls (11.5 vs. 10 days respectively).
Nevertheless the immunohistology of grafts from rejecting Stat1 KOfraction (D 5 15 6 3%) was observed, indicating preferential postglo-
merular vasoconstriction. Urine flow rate did not change. Acute hypo- mice showed a reduction of cytotoxic T-cells in the allograft when
compared with WT controls. Moreover intragraft gene transcripts forxemia induced similar systemic and glomerular hemodynamic changes
(DRBF 5 225 6 4%, DRVR 5 21 6 6%, DGFR 5 216 6 4%, DFF 5 the constant region of T-cell receptor b chain, indicating the total
T-cell mass, were significantly lower in Stat1 KO mice than in the WT12 6 4%) in animals whose bradykinin B2 receptors had been blocked.
These results clearly indicate that endogenous bradykinin accumula- controls. We conclude that Stat1 is not an absolute requirement for
transplant rejection. Nevertheless, Stat1 seems to be important in ini-tion does not contribute to the renal hemodynamic effects of hypo-
xemia. It is suggested that, in contrast to the plasma KKS, renal (tissue) tiating a cytotoxic T-cell immune response, as cytotoxic T-cells are
clearly diminished in rejecting Stat1 KO mice.KKS is not activated in newborn animals undergoing a hypoxemia stress.
A low pcr is not a good marker of malnutrition in chronic hemodialysis Mycophenolate-Mofetil (MMF) in ongoing chronic kidney allograft
dysfunction. B. Senn, Ph. Rochat, A.K. Schwarzkopf, Th. Weinreich,patients. D. Teta, A. Le Parc, G. Halabi, G. Massard, M. Magnone, Y.
Schutz, B. von Albertini, JP. Wauters. Centre Hospitalier Universitaire U. Binswanger. Nephrologie, Departement fu¨r Innere Medizin, Univers-
ita¨tsspital, Zu¨rich, Switzerland. Seventeen patients on triple therapyVaudois, Lausanne, Switzerland. nPCRw , 1 g/kg/day is now consid-
ered as the major index of malnutrition in chronic hemodialysis patients (prednisone, cyclosporine, azathioprine) exhibiting slowly deteriorat-
ing kidney allograft function were given 2 gr. of MMF daily while(CHD). Based on the routine trimestrial use of dialysate Urea Monitor
(Baxter Inc.), 38 CHD patients out of 60 treated in our unit for longer omitting azathioprine; they were followed for 3–8 months after this
change. Graft histology revealed chronic vascular lesions and intersti-than 3 months, were identified as having at least 3 consecutive measure-
ments of nPCRw , 1 g/kg/day. Since most of those patients appeared tial scarring. Grouping according to change of 1/Crs slope revealed the
following results:in stable clinical and nutritional state, several nutritional parameters
were evaluated in the present study. Five patients hospitalised during
1/Crs-slope Crs lmol/Lthe last 3 months (cardio-vascular reasons 1, gastrointestinal bleeding 1,
Time sincehypoglycemic coma 1, lower legs ulcers 1 and diabetic foot infection 1) after before at onset last value
transplantationand 2 patients refusing to enter the protocol were excluded from further
Groups Age years MMF MMF
analysis. Among the 31 remaining patients, the following parameters
A: successful 48 5.1 20.4260.68 0.0660.06 282697 247683were considered as abnormal: body mass index (BMI) ,20, anthropo-
n58 (39–61) (2 mo–10,5)metric measurements (arm and muscle arm circumferences, tricipital B: partially 46 8.3 20.2560.20 20.0460.02 393672 D
skinfold) if 2 out of 3 were pathological, serum albumin ,40 g/l, serum successful (36–54) (1.5–20)
n55pre-albumin ,0.20 g/l and mininutritionnal assessment questionnaire
C: failure 26 4.1 20.1660.61 20.1560.11 3336124 Dindex ,20. The patients with stable or increasing body weight were
n54 (23–32) (1–8,5)
considered as group A (n 5 23) while those having lost .3% of dry
D: dialysis treatmentbody weight during the last 4 months as group B (n 5 9). In group
A, the mean pathological malnutrition score of the different parameters Significant changes of 1/Crs-slopes were observed in group A patients
was 0.95 6 0.83 (highest score 5) while in group B mean score was only. -Roughly half of all patients included showed stable serum creati-
1.77 6 1.30. Higher BMI was found in group A (25.3 6 5.2 vs 21.5 6 nine levels after MMF during short time observation. Larger controlled
2.7 in group B). Based on these results, only the 9 patients of group studies are needed to document long-term results.
B (29% of the total patients with nPCR , 1 g/kg/day) can be considered
as malnourished. Conclusions: 1. In the present study, more than 70%
CHD patients with repetitive low nPCRw measurements do not show Glomerulonephritis in a patient with complement Factor I deficiency.
significant clinical and biological signs of malnutrition. 2. Obese pa- S. Sadallah*, E. Lach*, F. Gudat*, PJ. Spa¨th†, JA. Laissue#, and JA.
tients have a lower nPCRw due to a higher proportion of adipous Schifferli*. Univ. Basel*, Univ. Bern#, ZLB Zentrallaboratorium Bern†
mass. 3. The validity of the presently used nPCRw determinations Switzerland. We describe a patient with known factor I deficiency who
appears questionable and normalisation of the nPCR for lean body developed an immune complex (IC) glomerulonephritis (GN) at the
mass might be required. age of 46. The patient has recurrent otitis, sinusitis and pneumonia
starting in childhood. At age 25 he developed a purpura with histologic
evidence of vasculitis. The complement profile indicated absent Factor
Cytotoxic T-cells are diminished during allograft rejection in mice I, accompanied by evidence for an uncontrolled activation of comple-
deficient of Stat1 (signal transducer 1 activator of transcription). J. ment by the alternative pathway in blood, i.e. low C3, Factor H, Factor
Steiger, M. Hermle, D. Roubaty, M. Heim, G. Thiel. Univ. Basel, Swit- B, C5 and complement receptor 1 (CR1) on erythrocytes. The creati-
zerland. CD41 helper (Th) cells are key mediators in allograft rejec- nine was 112 mmol/L when first measured at age 42. The patient then
tion. These cells produce a variety of cytokines, which are very impor- developed proteinuria, hematuria and a slow rise in creatinine to 198
tant regulators of the immune response. In transplantation it has been mmol/L over 3 years. A renal biopsy showed a GN characterized by
shown that rejection is associated with the intragraft expression of focal and segmental sclerosis, with deposits of IgG, IgA and IgM,
IL-2 and IFNg while tolerance is characterised by IL-4 and IL-10. complement C3 and C4, and a loss of CR1 on podocytes. There is
evidence that continuous activation of the AP with C3 depletion leadsHowever the redundancy in the cytokine network is enormous and
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to GN: many patients with Factor H deficiency have a GN (7 out of A strategy for first operations of arteriovenous fistulas for hemodialysis
12). Pigs with Factor H deficiency have a dense deposit MPGN very with autogenous veins. C. Nadig, P. Heilberger, M. Kaufmann, D.
similar to patients with nephritic factor (NeF). Taken together these Raithel, Klinik fu¨r Gefa¨ßchirurgie, Klinikum Nu¨rnberg, Germany. The
data suggest that, although this is the first case reported, the association aim of this prospective study was to investigate the outcome of 34 first
of Factor I deficiency with GN is not fortuitous. We suggest that in operations of arteriovenous (AV) fistulas for hemodialysis between
this patient, many factors may have contributed to IC nephritis: i) loss September 1996 and February 1997 using autogenous veins. Prosthetic
of complement function, ii) excessive load of IC because of recurrent materials, regardless of their type, have a greater tendency toward
infections due to the acquired complement deficiency and iii) and loss thrombosis than autogenous tissue. Therefore, options for AV fistulas
of CR1 which is involved in the physiological disposal of IC. with autogenous veins should be preferred before nonautogenous ma-
terial is considered for dialysis access (Sabiston D.C., Textbook of
Surgery, 15th ed, 1997:430-1). The following priorities for AV fistulasIllness-specific and non-specific stressors and coping behavior in hemo-
were chosen: 1. Cimino fistula, 2. antecubital fistula: the antecubitaldialysis patients. S. Pedroli, Kantonsspital, St. Gallen, Switzerland. Goal
vein was anastomosed to the brachial artery, 3. brachiobasilic fistula:of study: Analysis of psychological and physical stressors and limita-
the basilic vein was dissected, moved to a superficial position andtions (both illness-specific and non-specific) and corresponding coping
anastomosed to the brachial artery. Because of the bigger diameterbehavior in patients on chronic hemodialysis (HD). Methods: 35 HD
of the vessels, which involves the risk of a steal syndrome or heartpatients were studied prospectively during a 1 month period with respect
to their individual style of attribution, ability to influence their situation failure, a nonabsorbable thread was used for the anastomosis of the
(controllability), emotional reaction to stress and coping behavior. Anal- antecubital and brachiobasilic fistula contrary to the Cimino fistula.
ysis was performed using a detailed questionnaire to be completed The results were as follows:
daily. Results: The most frequently reported stressors were somatic
problems related to HD (26.8%), psychological stress related to HD
Ante- Brachio-procedure (12.8%), sorrows of daily life (24.8%) and problems with
Simino cubital basilicsocial interactions and friendships (18.0%). The illness-specific and
Variables fistula fistula fistulathe non-specific stressors were attributed to: 1) circumstances, 2) the
patient himself and 3) other people. In illness-specific situations, men Number total 28 1 5
coped significantly better, in part due to their reaction by palliation, Number percent 82% 3% 15%
but exhibited significantly inferior compliance. Younger patients (,65 y) Fistula thrombosis, 14 days 3 0 0
were significantly more stressed both emotionally and physically. Their Diameter of vein* mm6sd 3.761.2 1.361.5 P,0.01
coping behavior, however, was more adequate, but compliance was
* Biggest diameter of the dammed vein of the distal forearm before operationworse when compared to patients ,65 y. Duration of HD (over 1
(Hitachi CS192, 7.5 MHz)year) correlated positively and significantly with dysthymic emotions
with respect to illness-specific stressors. Limited care patients were
In the case of a small diameter of the vein of the distal forearm,more anxious, sad, helpless, and challenged than patients on regular
one had to apply mostly a brachiobasilic fistula and only rarely anHD, but their compliance and coping behavior was significantly better.
antecubital fistula. We conclude that there is no need to use any pros-Increase in sadness, anxiety and physical limitations were also caused
thetic material with this strategy for first operations of arteriovenousby job activity, whereas coping was enhanced. Conclusions: These data
delineate that the majority of HD patients suffer from problems that fistulas.
should be treated by behavioral therapy and cognitive restructuring.
A 28-year-old man with acute anuric renal failure ingesting a nonsteroi-Not only CMV can infect renal allografts: BK-Viruses as a cause of
dal antiinflammatory drug after a minor accident. C. Nadig1, M. Gug-distinct morphological changes and graft dysfunction. V. Nickeleit, I.
ger 2, P. Eggenberger 1, Z Glu¨ck 1. 1Abt. Nephrologie, Regionalspital Biel,Binet, F. Gudat, P. Dalquen, M. Zeiler, H.H. Hirsch, G. Thiel, and M.J.
2Path. Inst. der Univ. Bern, Switzerland. Ten days after an accidentMihatsch. University of Basel, Switzerland. Introduction: Commonly,
followed by an uncomplicated surgical intervention to correct a luxa-CMV is associated with viral renal allograft infections. However, also
polyomaviruses (PV) of the BK type can affect kidney grafts. Recently tion of the acromioclavicular joint and repeated ingestion of mefenamic
(10/96–6/97), we observed 5 such cases, all of which under heavy immu- acid to relieve pain, a 28-year-old patient developed acute anuric renal
nosuppression (mainly tacrolimus), and with abundant PV infected failure (ARF). An acute allergic, mefenamic acid induced interstitial
cells in the urine. This cluster of 5 cases contrasts 13 CMV infections nephritis was believed to be the probable cause. Because of persisting
sporadically seen in 4211 graft biopsies. Method: 5 allograft recipients anuria, a renal biopsy was performed. The findings were compatible
(mean age: 46 6 2; 3 cadaver and 2 living unrelated grafts) showed graft with a membranoproliferative glomerulonephritis, and clearcut signs
infection by BK virus (9 6 2 months post transplantation; confirmed by of acute ischemic tubular necrosis or interstitial nephritis were lacking.
IHC with a monoclonal BK/JC specific antibody; PCR and EM). Sev- Because of a markedly increased serum antistreptolysin titer (1778 U/mleral renal allograft biopsies (range: 3–6) in each patient were studied.
versus a normal value of ,200 U/ml) and the presence of b-hemolyticResults: A) Cytology: BK virus infected epithelial cells along the entire
streptococci (group A) cultured from a throat swab, the diagnosis of annephron showed marked nuclear enlargement and polymorphism. The
acute poststreptococcal glomerulonephritis (PSGN) was made. Theintranuclear viral inclusion bodies were irregular (pale eosinophilic)
patient had suffered from a sore throat 4 weeks prior to ARF. Thewithout a well developed halo. Nucleoli were absent. Some nuclei
plasma concentrations of the complement component C3c alongshowed a more homogenous ‘ground-glass’ type appearance. B) Histol-
the glomerular membranes and partially in the mesangium. After 1ogy: BK virus associated changes were found in epithelial cells from the
urothelial umbrella cell layer to parietal epithelial cells along Bowman’s week of hemodialysis renal function recovered, and the creatinine level
capsule, most frequently in tubular cells. Early changes were primarily returned to normal. Vasodilator prostaglandins do not play a major
detected in the medulla in scattered collecting ducts. Later on during role in the regulation of renal hemodynamics in normal subjects, since
the course of the infection, also the proximal nephron was involved. the basal rate of prostaglandin synthesis is relatively low. In glomerular
Only occasionally, a mononuclear cell infiltrate and tubulitis was pres- disease, on the other hand, the increase in prostaglandin production
ent in the interstitium. Of special note, the infiltrate was not only found appears to represent an intranephronal adaptation to maintain the
around obviously infected tubuli. Within weeks, interstitial fibrosis glomerular filtration rate in the presence of an often marked reductiondeveloped, often marked around virally affected tubuli. C) Outcome:
in glomerular capillary permeability. If the intranephronal adaptationCreatinine levels deteriorated over 7 months from 291 6 178 to 484 6
is stopped through a treatment with NSAIDs, ARF may develop as326 mmol/l with 2 graft losses. Summary: Patients under tacrolimus,
observed in this patient. There is an increased tendency to use NSAIDsexcreting PV infected cells in the urine, and with a deterioration of
in upper respiratory tract infections, e.g. a sore throat. The possibilityrenal function might have a PV infection of their grafts. Histological
of a streptococcal infection and its sequels must be taken into consider-changes are characteristic and indicate a poor prognosis. Graft biopsy
is the gold standard for making the diagnosis of a PV infection. ation and NSAIDs must be used carefully in this situation.
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Duration of hospitalization due to the dialysis catheter after operation Simultaneous on-line hematocrit monitoring and bioimpedance analy-
sis during hemodialysis: relative value for definition of patients’ targetof an arteriovenous fistula for hemodialysis. C. Nadig, M. Leidig, T.
weight. M. Magnone, B. von Albertini, G. Halabi, Y. Schutz*, D. Teta,Schmiedeke, B. Ho¨ffken, Medizinische Klinik 4, Universita¨t Erlangen-
J.P. Wauters. Division of Nephrology, University Hospital and *Divi-Nu¨rnberg, Germany. The aim of this prospective study was to investi-
sion of Physiology, University of Lausanne, Switzerland. Setting ofgate the duration of hospitalization due to the dialysis catheter for
appropriate target ‘dry’ weight for hemodialysis patients is often diffi-short-term access after the operation of an arteriovenous (AV) fistula.
cult, because of the scarcity of objective means for this purpose in theThe study was conducted between Sept. 1996 and Febr. 1997. 17 pa-
presence of substantial interdialytic weight gains. Volume status of 18tients with end-stage renal failure received a new AV fistula and in
patients (age 60 6 18 yr., weight 66 6 14 kg) was assessed by continuous15 patients, a surgical revision was performed due to an AV-fistula
on-line hematocrit monitoring (Hct-M) and intermittent bioimpedancethrombosis, which prevented the fistula from being punctured for dial- analysis (BIA) during 24 hemodialysis sessions (Td 194 6 19 min,
ysis after the operation. Starting with the day of the operation, each
D weight 2.0 6 0.7 kg). Hct-M readings by the CritLineR instrument
succeeding day of hospitalization was categorized into one of three were expressed in variance to initial blood volume (DBV). BIA mea-
groups: 1. Hospitalization due to the AV fistula operation, 2. Hospital- surements, which included resistance (Re) and reactance (Rc) at 50
ization only due to the dialysis catheter, 3. Other reasons. The results and 0.5 kHz, were made at each incremental 0.3 l of ultrafiltration
were as follows: (UF). To avoid fluctuations at onset of dialysis due to priming and
posture, baseline for analysis was at 20.3 l UF. Results: Overall (n 5
24), observed DBV per session by Hct-M was 28.2 6 6.2%. Re andNew AV Revised
Rc at 50 kHz increased from 381 6 52 and 43 6 10 Ohm before toDays of hospitalization fistula AV fistula
443 6 63 and 55 6 15 Ohm after dialysis, respectively. Similar changes(mean6sd) N517 N515
were observed at 0.5 kHz. Overall measured variance of DBV, as
Due to the AV fistula operation 3.460.5 4.961.9 detected by Hct-M at each incremental 0.3 l UF, correlated with that
Only due to the dialysis catheter 14.667.0 10.869.6 of BIA (DRe at 50 kHz) with r 5 2.76. In 19 sessions of 15 patients,
Other reasons 5.768.5 3.167.4 DBV2 and DRe correlated with r 5 2.84, and DBV and DRc with r
5 2.80, respectively. These patients were defined to be cuvolemic. In
contrast, no such correlation was found in 5 sessions of 3 patients.Because of an increased risk of an infection, only 3 patients were
DBV changes were small or even positive, despite similar UF, whiledischarged overnight for a total of 6 days with a non-tunnelled catheter
Re and Rc at 50 kHz at onset of .98 6 12 for this treatment. The ratiofor short-term access. Alternatively, patients with a tunnelled dialysis
of Re at 0.5 kHz over Re at 50 kHz at onset of .98 6 .12 for this groupcatheter can be discharged with a much lower risk of infection. There was smaller than in the other patients (p,.05). There was evidence
is a variety of tunnelled dialysis catheters, but we believe that the of fluid overload in these 3 patients, since their target weight was
dialysis catheter CMD755 (Medcomp) is particularly suitable for tem- successfully lowered in subsequent treatments. Conclusions: 1. BIA
porary use. This catheter does not have a larger diameter (12 French) can be applied during dialysis to monitor intradialytic volume changes
than a non-tunnelled catheter for short-term access. The subcutaneous in response to ultrafiltration, 2. Specific differences between variations
tunneling a non-tunnelled catheter for short-term access. The subcuta- of BV by Hct-M and BIA are indicative of the clinical volume status
neous tunneling is performed from the vein insertion site (internal of the patients, 3. Hct-M and BIA contribute to define appropriate
target weight and therefore should increase dialysis tolerance andjugular vein) with a trocar attached to the catheter. For easy removal
decrease morbidity of hemodialysis patients.we fixed the catheter externally with a thread to the skin (no cuff).
We believe that such a tunnelled dialysis catheter should be used more
often instead of a non-tunnelled dialysis catheter for short-term access
Screening for sleep-apnea syndrome in hemodialysis patients by on-to cut down on the time and costs of hospitalization.
line hematocrit monitoring. M. Magnone, B. von Albertini, P.A. Des-
pland*, C. Oudy, J.P. Wauters. Division of Nephrology, *Neurology
Service, University Hospital, Lausanne, Switzerland. Sleep-apnea syn-
Expe´rience genevoise du traitement pre´emptif de l’infection a` cyto- drome is common in chronic dialysis patients and can cause consider-
me´galovirus. S. Moll, W. Wunderli, JE. Bornand, M. Leski. Division able morbidity. Detection of sleep-apnea episodes during dialysis re-
quires continuous surveillance and confirmation of hypoxemia.de Ne´phrologie, Laboratoire de Virologie, Hoˆpital cantonal, Gene`ve,
Continuous on-line hematocrit monitoring can also provide oxygenSwitzerland. L’infection a` cytome´galovirus (CMV) est un proble`me
saturation (O2-Sat) throughout the hemodialysis session by opticalmajeur en transplantation re´nale. La maladie a` CMV, favorise´e par
measurements in the arterial line. Sixty two stable patients (35 men,le status virologique du donneur et du receveur ainsi que par le type
27 women, mean age 60 years, range 36–79), on dialysis for a mean ofd’immunosuppression, pose l’indication a` un traitement curatif. Re´-
58 months (6–270), were investigated during at least two hemodialysiscemment, une nouvelle strate´gie the´rapeutique a e´te´ propose´e, base´e
sessions. All were dialyzed with polysulfone dialyzers and bicarbonatesur la surveillance de l’antige´ne´mie et l’administration d’un traitement dialysate. Screening criteria for presence of sleep-apnea were: clinical
pre´emptif avant toute apparition de symptoˆmes cliniques. Cette poli- observation of apnea episodes of $10 seconds, or episodes of ,10
tique est applique´e a` Gene`ve depuis mars 1994. L’antige´ne´mie a` CMV sec with O2-desaturation of .24%, measured by continuous on-line
est de´tecte´e sur les leucocytes pe´riphe´riques par des anticorps monoclo- hematocrit monitoring (CritLinet). Independent confirmation of sleep-
naux spe´cifiques de la prote´ine pp65 (de´tection par immunoperoxydase apnea was obtained by night-time respiratory-induced plethysmography
de`s mars 1994 puis par immunofluorescence de`s janvier 1997). 55 pa- (Edentraet). This instrument monitors respiratory flow, O2-Sat, EKG
tients ont e´te´ greffe´s et suivis par ce test (mars 1994 a` juin 1997). 17 body position, thorax impedance and snoring episodes. Results: Ten
patients (16%) met the above screening criteria during hemodialysis.patients ont positive´ leur Ag pp65 et ont rec¸u un traitement de gan-
None of them was obese, or had known abnormal pulmonary function.cyclovir (5mg/kg/12h pendant 2 semaines). Tous ont ne´gative´ leur test
Episodes of sleep with intermittent apnea episodes lasted between 5en fin de traitment. Depuis janvier 97, 8 patients ont re´cidive´, a` l (2
and 40 min. These were associated with a decrease of O2-Sat of .24%patients) ou plusieurs reprises (4 patients 2x, 1 patient 3x, 1 patient
in all 10 patients, as measured by the CritLine instrument. So far, 7 of5x) ne´cessitant a` chaque fois un nouveau traitement. Ces re´sultats
these patients were studied with plethysmography in the night followingpre´liminaires sembleraient indiquer une inefficacite´ du traitement pre´-
dialysis. All 7 patients showed sleep-apnea episodes lasting 10–30 secemptif tel qu’il est recommande´ actuellement: ses modalite´s (dure´e, of the mixed type (central & obstructive). Apnea index was abnormal
adaptation du traitement immunosuppresseur) demanderaient a` eˆtre at 16/hour. Mean O2-desaturation episodes were 40/night (range 16–97),
re´e´valuee´s. De meˆme, l’appariement en fonction du status virologique with the lowest O2-Sat reaching 73%. Conclusions: Sleep-apnea was
du couple donneur-receveur, actuellement ne´glige´ en raison de la prio- detected by intradialytic continuous on-line hematocrit monitoring in
rite´ donne´e a` la compatibilite´ HLA, pourrait eˆtre a` l’avenir mieux pris 16% of a sample of chronic hemodialysis patients. Night-time respira-
en compte. Toutefois, l’augmentation de la sensibilite´ du test pourrait tory plethysmography confirmed this syndrome in all the patients in
whom it was applied.eˆtre seule en cause et les traitements ite´ratifs injustifie´s.
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Further evidence for disturbed vitamin B6 metabolism in idiopathic Urinary protein, albumin and b-NAG to creatinine ratios in a normal
pediatric population. V. Matos 1, G.v. Melle 2, M. Market 3 and J.P.calcium stone formers (ICSF) with hyperoxaluria (HO). A. Kaelin, R.
Guignard 1. Service de Pe´diatrie 1 et Laboratoire de Chimie Clinique 3,Mosimann, K. Farina, A. Vaucher, G. Haueter, Ph. Jaeger, Policlinic
CHUV Institut Universitaire de Me´decine Sociale et Pre´ventive 2, Lau-of Medicine, University Hospital, Berne, Switzerland. ICSF with HO
sanne, Switzerland. An elevated urinary excretion of protein (Prot),sometimes normalise urinary oxalate on B6 therapy. Since B6 acts as a
albumin (Alb) and N-ace´tyl-b,D-glucosaminidase (b-NAG) can becofactor in the transamination reaction between glyoxylate and glycine,
the first sign of glomerular or tubular disease. In order to determinethus curtailing oxalate production, B6 deficiency has been postulated
reference values for the urinary excretion of these substances in chil-to account for HO at least in some ICSF, although this remained
dren, their urinary concentration was measured in the second morningunproven. To address this issue 5 healthy volunteers and 16 ICSF with
urine and expressed as a ratio to creatinine (Cr) concentration. 410HO with or without concomitantly elevated urinary glycolate were
healthy infants, children and adolescents (197 females, 213 males; age:studied on free choice diet, and urinary 4-pyridoxic acid (U-4PA,
1 month to 17 years; median 4.5 years), from kindergartens and schoolsreflecting B6 intake and/or absorption) as well as serum concentration of Lausanne, participated in the study. 62% had two urine collectionsof pyridoxal-59-phosphate (S-P59P, reflecting activated metabolite of
one week apart, making thus possible to determine the intra-individualB6) were measured both before (bef) and after (af) 7 days on B6 variation. Urinary Cr, Prot and Alb were determined respectively by(300mg/d). Results (x 6 SD) were: a kinetic Jaffe method, Coomassie blue and immunoturbimetry;
b-NAG concentration was determined by enzymatic reaction. Sex dif-
ICSF Normal ferences were assessed and excluded by the Wilcoxon signed rank test.
n516 n55 A quantile regression in terms of age was used to determine the 5th
and the 95th percentiles.Oxalate x V lmol/24 h 4596162 3586151
Glycolate x V lmol/24 h 5236231 5456198
Prot/Cr Alb/Cr b-NAG/CrU-4PA/creatinine (bef) 3.9331024 4.6431024
g/mol g/mol U/mmollmol/l/lmol/l 63.6831024 60.5731024 Age years
U-4PA/creatinine (af) 4.4631022 3.4331022 /percentile 5 95 5 95 5 95
lmol/l/lmol/l 61.4531022 61.6031022
1⁄12–6⁄12 13.0 80 1.1 14 0.40 4.00S-P59P (bef) nmol/l 29.8620.3 60.9621.3
6⁄12–1 12.0 60 0.9 12 0.40 2.50S-P59P (af) nmol/l 5046636 4406145
1–2 9.0 45 0.9 10 0.36 1.40
2–3 7.5 30 0.8 8 0.30 1.10Before B6 loading, U-4PA was below the lowest normal value in 14 3–5 6.3 20 0.8 7 0.27 0.70patients, suggesting deficient B6 ingestion and/or absorption; moreover 5–7 5.0 19 0.7 7 0.20 0.60
S-P59P was undetectable in 5 patients. After B6, S-P59P increased in 7–10 4.3 18 0.6 7 0.17 0.55
all patients, although remaining below the lowest normal value in 6 10–14 3.4 18 0.5 7 0.13 0.55
patients, thus suggesting deficient B6 activation. Conclusion: These 14–17 3.4 18 0.5 7 0.12 0.55
preliminary data suggest that B6 metabolism is disturbed in some ICSF
with HO. We provide reference values for urinary Prot/Cr, Alb/Cr and b-NAG/Cr
in the pediatric population. These values decrease significantly with age.
Role of citrate in determining calcium oxalate (CaOx) crystal morphol-
Urinary marker proteins in acute interstitial rejection of renal trans-ogy and crystallization kinetics in presence of normal and stone-former
plants. N. Frischmuth, A. Regeniter*, A. Scholer*, WH. Siede**, V.Tamm-Horsfall protein (THP). B. Hess, S. Jordi, L. Zipperle, E. Et-
Nickeleit***, M. Mihatsch***, G. Thiel. Dep. of Nephrology, *Centraltinger, R. Giovanoli, Ph. Jaeger, Departement Innere Medizin, Med.
Laboratory, and Pathology***, Kantonsspital Basel, Switzerland;Poliklinik und Labor fu¨r Elektronenmikroskopie der Universita¨t Bern,
**Central Laboratory, Klinikum Lippe-Lemgo, Lemgo, Germany.Switzerland. Nucleation (N) and aggregation (A) of CaOx crystals out
Acute interstitial cellular rejection of renal transplants is characterizedof a supersaturated stirred solution (500 rpm, 378 C, 200 mm NaCl, 10
morphologically by tubulitis and by interstitial lymphocellular infiltra-mm Na-acetate, pH 5.7, 5 mm Ca, 0.5 mm Ox) were measured by time-
tion. The purpose of the present study was to evaluate whether tubulitiscourse readings of OD620 (Urol Res 23: 231, 1995), and samples for in acute interstitial rejection is associated with albuminuria and tubularscanning electron microscopy (JEOL JSM-840) were obtained at differ-
proteinuria characterized by increased excretion of al-Mikroglobulinent times. Rates of N (max. slope of increase of OD620 with time, SN) (al-M), MG 33.000 and of retinol binding protein (RbP), MG 21.000.and A (max. slope of decrease of OD620 with time, SA) were measured Methods: Albumin/creatinine, al-M/creatinine and RbP/creatinine ra-
in presence of 3.5 mm citrate (CIT), normal THP (nTHP) and abnormal tio were calculated directly before renal biopsy prospectively from
THP from a recurrent CaOx stone former (SF-THP) at 30 mg/l as well 01/96–9/97. Proteins were measured nephelometrically. Tubulitis was
as of CIT combined with either THP. Sialic acid (SA) content of THPs defined as infiltration of more than one non-atrophic tubulus by lym-
was measured colorimetrically after acid hydrolysis. Compared with phocytes in biopsies with interstitial lymphocellular infiltration. These
standard conditions (0% inhibition), inhibitory activities (%, mean 6 (n 5 18) were compared with biopsies showing interstitial infiltration
SE) by various modifiers were as follows: but without tubulitis (one or less infiltrated tubulus in the biopsy;
n 5 31). No other pathologic findings in the biopsy were allowed
(i.e. no glomerulitis or glomerulopathy, no vascular proliferation orCIT nTHP SF-THP CIT/nTHP CIT/SF-THP
vasculopathy, no signs of CyA-toxicity such as isometric vacuolisation
SN 8761* 4667* 211611 90611 836161 of tubular cells or arteriopathy). Results are shown in the table below:
SA 7061* 8166* 240610* 100608 496128x Median (MEAN 6 SEM), *p , 0.05, **p , 0.01 non-tubulitis vs.
tubulitis biopsies with interstitial lymphocellular infiltration, Mann-*p,0.001 vs. standard; 8p,0.025; 1p,0.005 vs. no CIT; xp,0.013 vs. CIT/nTHP
Whitney U/Median Test.
In presence of nTHP (SA content 18.7 mg/mg THP), mainly single
CaOx crystals (diameter up to 12 mm) formed, and A was inhibited, Biopsies with
whereas SF-THP (SA content 5.3 mg/mg) was an A promoter (aggre- interstitial Albumin/creat a1-M/creat RbP/creat
gates up to 30 mm diameter). Irrespective of the presence of normal infiltration mg/nmol mg/mmol mg/mmol
or abnormal THP, however, CIT always induced formation of small
No tubulitis 4.3 (10.362.4) 5.1 (6.060.8) 0.06 (0.3160.1)crystals (diameter up to 10 mm), and large aggregates were never
n531 n526observed. Conclusions: 1) CIT appears to be the primary determinant
Tubulitis 8.3 (9.761.8) 8.7 (12.062.1)* 0.70 (0.8160.2)**of CaOx crystal morphology and of rates of crystalization in vitro; 2)
n518 n514CIT always induces formation of small and disaggregated crystals, even
Normal limit ,2.26 ,1.58 ,0.11when aggregation-promoting SF-THP with low SA content is present.
Abstracts 1155
Conclusion: The presence and pattern of tubular proteinuria is helpful Differential diagnosis: In spite of rising plasma Na1 levels polyuria
in detecting tubulitis and seems to distinguish between acute interstitial persisted. Thus hypernatremia was not primarily due to dehydration,
rejection and non aggressive interstitial infiltration. Whether the in- but had to be caused by renal water loss either by solute or water
crease of albuminuria is due to impairment of glomerular charge barrier diuresis. Water diuresis (central or renal diabetes insipidus) was ruled
or reduced tubular reabsorption remains to be determined. out by repeatedly measured hyperosmotic urine and a calculated nega-
tive free water clearance (CH2O), indicating undisturbed urinary concen-
trating ability. Rising blood urea concentration and excessive urea
Sandimmun Neoral dosage as mg/KgBW. M.P. Fischler, Ph. Rochat, excretion, which peaked at over 2000 mmol/24h indicated urea induced
U. Binswanger. Nephrologie, Departement fu¨r Innere Medizin, Univers- osmotic diuresis. Massive catabolism of body proteins due to severeita¨tsspital Zu¨rich, Switzerland. Background: Monitoring of cyclosporin
illness and inadequate caloric supply must have led to the endogenous(CyA) dosage by measuring through levels lacks accuracy. Improved
production and urinary excretion of large quantities of urea whichpharmacokinetics were documented for the Neoral formulation. This
occurred simultaneously with the development of hypernatremia. Thestudy was undertaken to compare estimated area under the curve
amount of free water, needed to excrete this tremendous urea load(AUC) with through levels as well as dosage (mg/KgBW). Methods:
was up to 3.4 l/d (estimated indirectly by calculating the electrolyteAll patients received Sandimmun Neoral twice daily. One single dose
free water reabsorption TeCH20). The cause of hypernatremia becomesamounted to 1.91 1/2 0.66 mg/KgBW. Data were obtained between
apparent: free water loss by urea osmotic diuresis. Conclusion: Differ-2/97 and 5/97. 38 stable patients (21 male, 17 female, median age 44y.,
ential diagnosis of hypernatremia in severely ill patients with metabolicrenal allograft transplantation between 6/84 and 4/97) were included.
The whole blood CyA concentration was measured by monoclonal stress should include osmotic urea diuresis.
assay TDx (Abbott). Blood samples were taken at time 0,1,2 (8 pa-
tients) and 3 hours after CyA Neoral dosing. AUC was calculated by
the formula: AUC 5 5.189 3 (Oh) 1 1.267 3 (1h) 1 1.267 3 (1h) 1 Water soluble vitamins, oxalic acid and homocysteine levels in haemo-
4.15 3 (3h) 1 135.079 (F. Gaspari et al, JASN,4/1997;8:647–652). Re- dialysis patients receiving long-term vitamin supplementation. E. Des-
gression analysis was performed choosing through level and dose (mg/ combes, N. Andrey-Brochud*, O. Boulat8, F. Perriard** and G. Fellay.KgBW) as independent variables. Mean AUC prediction and 95%
Dialysis Unit, *Dietetical Service, *Clinical Laboratory, Hoˆpital Can-confidence intervall of the mean are shown for ranges of independent
tonal, Fribourg, Switzerland and 8Clinical Chemistry Laboratory,variables observed under clinical conditions. Results:
CHUV, Lausanne, Switzerland. In a previous study we investigated
the need for water soluble vitamin supplements for patients on mainte-Regression analysis
nance haemodialysis (HD) (Kidney Int 43:1319–28, 1993). Since then
Trough lg/L 100 200 300 all the patients at our centre receive an oral post-dialysis multivitamin
supplement (2 or 3 times/week) containing the following doses ofAUC ng3h/ml 3325 5185 7049
vitamins: thiamine hydrochloride 100 mg, riboflavin 20 mg, pyridoxine(2761–3889) (4881–5489) (6569–7521)
hydrochloride 50 mg, folic acid 1 mg and ascorbic acid 500 mg (Dialvit,[34] [12] [14]
Laboratorium Dr. Bichsel AG, Interlaken). The purpose of the present
mg/KgBW 1 2 3 study was to perform a cross-sectional long-term re-evaluation of the
vitamin status and to investigate in more detail the plasma oxalic acidAUC ng3h/ml 3811 5577 7343
and total homocysteine levels associated with this vitamin supplement.(3179–4442) (5207–5947) (6628–8058)
[33] [13] [19] Forty-one chronic HD patients were evaluated. The mean age was
63611 years and they had been on dialysis for 565 years. They were( ), 95% confidence interval; [ ], 95% interval as % of mean
dialysed 2 (n 5 18) or 3 (n 5 23) times a week by means of short
Peak CyA concentration occurred in 5 patients (14%) 3 hours after (3:00 to 4:30 hours) high-efficiency HD with blood pump flows of
drug administration. Conclusion: Precision of predicting AUC from 300–400 ml/min and either cellulose triacetate (n 5 14), polyamide (n 5
through concentration or dose as mg/KgBW (expressed as % deviation 19) or PAN (n 5 8) membranes. The determinations of vitamin levelsfrom regression lines) are similar. For the future we propose to deter- and/or vitamin-dependent enzymatic activity showed that all but onemine the AUC once for each patient for documentation of chronic
of the patients had adequate vitamin levels. The exception was a veryslow absorption; once stable dosage according to through levels is
malnourished patient who had ascorbic acid deficiency. Marginal vita-established, surveillance according to dosage as mg/KgBW seems justi-
min levels were rare, except for folic acid (n 5 7) and for pyridoxine-fied. This method would be less expensive and faster.
dependent EGOTo activity (n 5 11). This was observed mostly in
patients dialysed twice a week, thus receiving lower doses of supple-
ment, and who had significantly lower levels of these two vitamins.Life threatening hypernatremia induced by urea osmotic diuresis. M.J.
Dickenmann, F.P. Brunner. Abteilung Nephrologie, Kantonsspital Ba- Our patients were taking on average 256 6 68 mg of vitamin C per
sel, Switzerland. Presentation of case: Allogeneic bone marrow trans- day, including 77 6 66 mg/day with their meals (estimated by a 3 day
plantation was done in a 36-year-old man with acute myeloid leukemia. alimentary report). Mean plasma vitamin C was 12.9 6 6.2 mg/L (N 5
Post transplantation pneumonia occurred and the patient had to be 4–15 mg/L) and was significantly higher in the group of patients dialyzed
intubated. Parenteral nutrition was stopped and thereafter nutrition three times a week (15.3 6 6.6 vs 9.8 6 4 mg/L, p 5 0.0034). Four
was limited to the glucose in the infusions. In the second week post patients had plasma levels .20 mg/L. Mean oxalic acid (OA) concen-
transplantation the patient developed progressive hypernatremia and tration was 56 6 17 mmol/L) and was significantly higher in the patientsa rapidly rising blood urea concentration, combined with a severe
dialysed three times a week (67 6 14 vs 44 6 9 mmol/L, p 5 0.0001).polyuria (up to 7 l/d). A subarachnoid hemorrhage, probably induced
However no patient had OA levels exceeding 3 times the normal range.by hypernatremia was observed. Blood pressure, heart rate and central
Thus the secondary hyperoxalemia observed in our patients was invenous pressure remained within the normal range.
the range of that observed in HD patients not taking extra vitamin C
and therefore does not seem to be aggravated by the supplementsOct 27 Oct 29 Oct 31 Nov 01 Nov 02
given. A slight to moderate hyperhomocysteinemia was present in
Plasma sodium almost all patients in spite of the vitamin supplements, with a mean
mmol/l 145 148 155 156 162 value of 31 6 13 mmol/L (N , 15 mmol/L). Therefore, for a 3 month
Plasma creatinine period, we increased the supplement of folic acid from 1 to 6 mg post-
lmol/l 97 136 138 141 132 HD 2 or 3 month period, we increased the supplement of folic acid
Plasma urea from 1 to 6 mg post-HD 2 or 3 times/week (corresponding to <1.7 to
mmol/l 18.8 23.6 26.8 34.5 36.5 2.6 mg/day). At the end of the 3 months the total homocysteine levels
Urine volume had significantly (p 5 0.0016) decreased to 24 6 9 mmol/L, with normal
ml/day 6100 5195 4835 6610 7205 values in 7 patients. Concurrently folic acid plasma levels increased
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to 14.4 6 2.5 ng/ml (N , 17 ng/ml). In conclusion our data show that: Target haemoglobin was maintained stable between 110 and 120 g/l.
The results are summarized in the following table:(1) the post-HD vitamin supplement given provides sufficient vitamin
levels in almost all the patients; (2) the plasma vitamin C levels are
notably higher than normal in a few patients dialysed 3 times/week Follow-up
but the degree of the secondary hyperoxalemia found in our patients Month 0 Month 6 Month 12 (month 18)
is comparable to that reported for HD patients not receiving vitamin Parameter n525 n525 n525 n521
C supplements; (3) a supplement of 12–18 mg/week of folic acid reduces
Haemoglobinthe hyperhomocysteimenia of HD patients while folic acid plasma
g/l 115610 119611 118610 11768levels remain within the normal range. Haematocrit 0.3660.03 0.3560.03 0.3560.03 0.3660.02
Serum iron
lg/l 10.663.2 12.165.4 14.764.6* 14.465.4*
TransferrinHydroxyethylstarch (HAES) associated transient acute renal failure
saturation % 26.669.0 30.4613.3 43.6614.9*8 41.8617.2*8after epidural anesthesia for cesarean section. M.J. Dickenmann, E.
Ferritin ng/ml 3276183 3276170 4676152*8 5196238*8Cynke, F.P. Brunner, G. Thiel. Abteilung Nephrologie, Kantonsspital
EPO doseBasel, Switzerland. The potential effects of HAES on renal function
IU/week 792064102 712063468 576063887*8 536864219*8are controversial. Although HAES appears to be protective against
EPO doseischemic damage in kidney transplants when added to kidney transplant
IU/kg/week 120660 109651 87655*8 81659*8perfusion solutions, it has been incriminated to rarely cause acute renal
failure. We now report on two full term gravidae who developed Student’s t test for paired data: *p,0.01 compared to month 0; 8p,0.01 compared
to month 6acute transient non-oliguric renal failure after epidural anesthesia for
cesarean section. Volume substitution in both was done with HAES
Haemoglobin and haematocrit levels were stable. Iron concentration6% (Expafusin Sinet) 500 ml and 1000 ml, respectively. Acute non-
and transferrin saturation increased progressively, but the changesoliguric renal failure occurred with a peak plasma creatinine level of were significant only at month 12. Mean FE levels were unchanged
535 mmol/l on day 3 and 419 mmol/l on day 2, respectively. Renal during the first 6 months but significantly increased thereafter. Concur-
function recovered spontaneously. The plasma creatinine was 96 mmol/ rently a significant decrease (<30%) of the weekly mean EPO doses
l on day 9 and 89 mmol/l on day 7 after caesarean section. Other was observed. Follow-up data at month 18 confirm these findings. The
potential causes of acute renal failure could be excluded. Discussion: iron supplementation needed to maintain target FE levels was quite
We suppose that the acute renal failure observed in our two patients different among the patients: 3 needed ,1 g/year, 11 needed 1–2 g/
was related to the use of HAES. HAES used as a volume expander year, 8 needed 2–3 g/year and 3 needed 3–4 g/year. With the IV-iron
in brain dead organ donors caused renal histological lesions resembling supplementation given in the second part of our study the risk of
osmotic nephrosis. These lesions involved the proximal and distal tu- having a transferrin saturation ,15% was 1.4% and ,20% was 5.9%.
bules. Severe alterations of proximal tubules were also described in Only one patient had repeated values ,20% in spite of high FE levels.
Thus the routine measurement of the transferrin saturation is notdogs after complete blood exchange with HAES. The major portion
necessary if the iron is prescribed according to our design and should(70–80%) of the injected HAES is eliminated through the kidneys. It
be limited to patients with a poor response to EPO. In conclusionis believed, that the smaller molecules (MW less than 50,000 daltons)
our data show that: (1) a systematic prescription of intravenous ironare excreted unchanged by glomerular filtration leading to a high
saccharate based on monthly ferritin levels allows an adequate long-amount of osmotically active small molecules in the ultrafiltrate. GFR
term iron supply without the risk of iron overload; (2) this strategyin our two patients may have been decreased due to decreased circulat-
significantly improves the response to EPO therapy; (3) there is a greating blood volume because of venous pooling in the lower extremities
variability among patients in the amount of IV-iron needed to maintainby the epidural anesthesia. This may have led to a highly viscous
target levels of ferritin.ultrafiltrate with tubular stasis and an osmotic nephrosis of tubular
cells by reabsorption of HAES molecules inducing acute renal failure.
Conclusion: The use of HAES in volume depleted patients may induce
Flucloxacillin & cyclosporine A: an unrecognised but relevant interac-acute renal failure due to tubular stasis by osmotic nephrosis. tion in renal transplant recipients. E. Cynke, I. Binet, W.E. Haefeli*,
G. Thiel. Abteilung Nephrologie, Abteilung Klinische Pharmakologie*,
Kantonsspital Basel, Switzerland. Staphylococcus aureus septicaemia
is a common complication observed after transplantation and flucloxa-Systematic supplementation with intravenous iron saccharate in pa-
cillin (Flx) is considered as the first line antibiotic. Until now, theretients on chronic haemodialysis (HD) and improved response to rHu-
are no reports about a possible interaction between cyclosporine Aerythropoietin (EPO). E. Descombes and G. Fellay. Dialysis Unit.
(CsA) and Flx. We report on an apparent interaction between oralHoˆpital Cantonal, Fribourg, Switzerland. Studies have shown that an
CsA and i.v. Flx which was identified by retrospective chart review ofadequate supply in bioavailable iron is critical for an optimal response
7 kidney transplant recipients with Staphylococcus aureus septicaemia.to EPO therapy. However, the amount of iron needed to provide the
Results: CsA trough levels (TL) fell 55 6 17% (mean 6 SD) withinnecessary long-term supply to chronic HD patients is not well defined.
3.6 6 1.5 days after starting Flx. To achieve the same target TL asMoreover, the laboratory tests available to monitor the iron status
before Flx, the CsA dose had to be increased 2.2 6 0.6 fold. Despitehave known limitations. We investigated the amount of IV iron saccha-
dose adjustment, a biopsy-proven rejection was diagnosed in 3 patientsrate (IV-iron) permitting long-term adequate supplementation while
10 6 2 days after the beginning of Flx. The CsA TL returned to normalavoiding the risk of iron overload (ferritin .800 ng/ml). All the patients
values 1.8 6 1 days after discontinuation of Flx. Discussion: CsA ison maintenance HD at our centre receiving EPO were considered metabolised in the liver by the cytochrome P-450 enzyme system. Three
for inclusion, except those having neoplasia, chronic inflammation, mechanisms of interaction are known: 1) induction of liver enzymes
bleeding disorders or persistent ferritin (FE) levels .600 ng/ml. leading to a decrease of CsA TL. 2) inhibition of liver enzymes leading
Twenty-five patients completed the one year period of the study which to an increase of CsA TL. 3) modified gastrointestinal absorption
was divided into two periods of 6 months. During the first 6 months leading to a decrease or an increase of CsA TL. In our cases, the
all the patients received 50 mg of IV-iron fortnightly (IV-iron was mechanism of interaction is unclear; the rather rapid onset of the
stopped when FE levels exceeded 600 ng/ml). In a majority of patients interaction and the prompt return to previous CsA dose requirements
(15/25) this regimen was insufficient to maintain the iron stores as after discontinuation of Flx argue against hepatic enzyme induction.
suggested by falling FE levels. Thus in the second part of the study Whether this clinically relevant interaction was caused by changes in
the dose of IV-iron was based on monthly FE levels: 2100 mg per CsA absorption or distribution will have to be addressed in prospective
week for FE ,200 ng/ml, 100 mg fortnightly for FE 200–400 ng/ml, studies. Conclusions: Flx leads to a decrease of CsA TL which can
cause allograft rejection. Therefore, a cautious monitoring of the CsA50 mg fortnightly for FE 400–600 ng/ml and none for FE .600 ng/ml.
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TL with consecutive dose adjustment is strongly recommended in case till dialysis (22 years), living/cadaveric donation, HLA matching, mean
HbA1c (8.0 6 0.3 vs. 7.4 6 0.2, p 5 0.13) or mean sitting blood pressureof combined therapy with Flx.
post transplantation. Recurrence incidences were similar in the pres-
sure post transplantation. Recurrence incidences were similar in the
pre-CsA and the CsA eras. By Kaplan-Meyer analysis, the probabilityIntravenous magnesium sulphate induces renal vasoconstriction in
newborn rabbits. S. Brenna, M. Thonney-Viani, F. Cachat and J-P of remaining recurrence-free was 84 6 5% at 5 years and 61 6 13%
at 10 years (81% and 55% for type I diabetes). Diabetic nephropathyGuignard. Service de Pe´diatrie, CHUV, Lausanne, Switzerland. At
pharmacological doses magnesium sulphate induces intense systemic was considered responsible for graft loss in 5 of the 14 patients; the
same number of grafts in this group was lost by patient death. Summary/vasodilatation, muscle relaxation and sedation. In the neonate magne-
sium sulphate is given to blunt the vasoconstriction present in persistent Conclusions: Diabetic nephropathy recurs in <20% of type I diabetics
from year 1 to 5 after transplantation and in <45% till year 10. Duepulmonary hypertension of the newborn (PPHN). The aim of this
study was to investigate the effects of magnesium sulphate on the to associated morbidity and mortality, it is not a major cause of graft
loss. Such early disease recurrence in a healthy kidney, sometimesmicrocirculation and vascular tone of the immature kidney. The experi-
ments were performed in 10 anaesthetised and mechanically-ventilated detectable at 1 year after transplantation, contrasts with the diabetes
effect on native kidneys, where mere microalbuminuria takes 5 years tonewborn rabbits, inulin and PAH being used as indices of glomerular
filtration rate (GFR) and renal blood flow (RBF), respectively. Mean develop. Speculative explanations for this rapid course include postural
hypotension/hypertension, glomerular hyperfiltration and cytokine/arterial pressure (MAP) and heart rate were continuously recorded.
Renal function and hemodynamic parameters were measured during growth factor alterations from rejection of CsA.
the control period and two treatment periods after the iv administration
of a loading dose of magnesium sulphate (100 mg/kg) injected in 5
minutes, and followed by the continuous infusion of 50 mg/kg/hour. Polyomavirus kidney graft infection under tacrolimus: a cause of renal
dysfunction and graft loss. I. Binet, V. Nickeleit*, O. Prince*, H. Hirsch§,Comparing the control period with the two magnesium infusion periods
(P1 and P2), the results showed a significant decrease (p , 0.001) in P. Dalquen*, M. Mihatsch*, G. Thiel. Abt. Nephrologie, Institut Mikrob-
iologie§, Dept. Pathologie*, Kantonsspital Basel, Switzerland. No caseMAP (mean P1 5 212.4%, P2 5 25%), GFR (mean P1 5 211.7%,
P2 5 26.6%) and RPF (mean P1 5 218.7%, P2 5 210.7%) and an of Polyomavirus (PV) kidney graft infection was recorded at our institu-
tion among 596 transplantations performed between 1.1.1985 andincrease in the filtration fraction (FF) (mean P1 5 19%, P2 5 16%;
p , 0.01). The renal vascular resistance (mean P1 5 115.3%, P2 5 1.8.1995. However, among 127 transplantations performed between
1.8.1995 and 1.10.1997, six cases of graft infection with PV were diag-117.6%) rose significantly (p , 0.01). A marked decrease in the frac-
tional excretion of potassium, but not of sodium was observed (mean nosed by biopsy-proven typical virus-induced tubular changes and by
the urinary excretion of PV infected cells (PIC). Graft biopsies wereP1 5 27.9%, P2 5 217.7%) (p , 0.001). The present results demon-
strate vasoconstriction of the immature renal vascular bed after iv all performed because of a rise in creatinine in the context of recurrent
rejection episodes. Since 1.1.1985, the urine cytologies of 483 recipientsadministration of magnesium sulphate. The increase in FF suggests
preferential efferent vasoconstriction. Whether such a vasoconstriction showed that 29 excreted a significant amount of PIC, among them 23
with no evidence of viral kidney graft infection (“KI2”), and the 6also occurs in human neonates with PPHN given magnesium sulphate
remains to be demonstrated. recipients with biopsy-proven PV graft infection (“KI1”). The compar-
ison of these two groups shows the following results:
Early recurrence of diabetic nephropathy in transplanted kidneys. H.A. KI1 KI2
Bock1, T. Eckert2, M. Mihatsch3, G. Thiel2. Nephrologie Kantonsspital n56 n523
Aarau1, Nephrologie2 und Pathologie3 Kantonsspital Basel, Switzerland.
Follow-up months 1565 63630Background/Methods: Diabetic nephropathy is believed to recur in
Switch from CyA to TAC 100% (6)* 9% (2)transplanted kidneys in a similar time course as in native kidneys i.e.
Switch from AZA to MMF 67% (4)* 0% (0)within 10–15 years. To verify this concept, we searched for evidence
Induction with ATGAM 83% (5) 9% (2)of diabetic nephropathy recurrence in the charts of all diabetic patients
Patients with ALP re-therapies 67% (4) 35% (8)who were transplanted in Basel between 1967 and Mid-1996 and whose
Number of MP pulses/patient 1467 1066graft had functioned beyond the 1st year. All patients had annual Last creatinine lmol/l** 3466151 144646determinations of proteinuria, renal function and HbA1c. “Definite” Graft loss 33% (2) 13% (3)recurrence was defined as biopsy-proven glomerulosclerosis 1 arterio-
* Switch before biopsy-proven diagnosis of kidney graft infection with PVlosclerosis 1 proteinuria . 1 g/24h, “probable” recurrence as crescendo
** For recipients with functioning graft at the end of follow-up (1.9.97)proteinuria .2 g/d at a creatinine ,250 mmol/l. Results: Diabetic ne-
Abbreviations are: TAC, tacrolimus; AZA, azathioprine; MMF, mycophenolatephropathy recurred in 14 of 64 kidney transplants to diabetic patients
mofetil; ALP, anti-lymphocyte preparation; MP, methylprednisolone(“definite” recurrence in 12, “probable” in 2), at a median time of
3.4 years (11 mo. to 11 yrs.) after transplantation. All patients with Conclusion: in heavily immunosuppressed kidney recipients treated
recurrence had Type I diabetes, whereas 12 of the 50 recurrence-free with TAC and who excrete PIC in the urine, graft dysfunction can be
patients had Type II diabetes (p < 0.05). Patients with and without associated with an active PV graft infection which should be looked
for in transplant biopsies.recurrence did not differ with respect to age, gender, diabetes duration
